| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2015 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 4 | Q2 2019 | 75.3% |
| ISHARES TR | 4 | Q2 2019 | 4.9% |
| Vanguard Intl Equity Index Fund | 3 | Q2 2018 | 100.0% |
| CELGENE CORP | 2 | Q2 2019 | 3.1% |
| VERTEX PHARMACEUTICALS INC | 2 | Q3 2018 | 1.6% |
| Vanguard INTL Equity Index Fund | 1 | Q4 2017 | 95.2% |
| ALPHABET INC | 1 | Q2 2019 | 7.3% |
| United Technologies Corp | 1 | Q4 2018 | 6.9% |
| GILEAD SCIENCES INC | 1 | Q2 2019 | 6.0% |
| Wynn Resorts Ltd | 1 | Q4 2018 | 4.8% |
View HIGHLAND ASSOCIATES INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-08-08 |
| 13F-HR | 2019-04-30 |
| 13F-HR | 2019-01-15 |
| 13F-HR | 2018-10-22 |
| 13F-HR | 2018-08-06 |
| 13F-HR | 2018-04-06 |
| 13F-HR | 2018-01-24 |
| 40-APP/A | 2012-10-16 |
| 40-APP/A | 2012-09-20 |
| 40-APP/A | 2012-07-20 |
View HIGHLAND ASSOCIATES INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.